ZEPBOUND 15mg/0.5ml (Tirzepatide Vials) 15mg/0.5ml

ZEPBOUND 15mg/0.5ml (tirzepatide) is a prescription injectable solution for type 2 diabetes management. Store between 2–8°C and protect from light. Always follow healthcare provider guidance for use.

Strength

15mg/0.5ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

LILLY ELI & CO

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Tirzepatide, the active ingredient in ZEPBOUND 15mg/0.5ml, is used alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes. It belongs to a class of medications that help regulate glucose by targeting multiple pathways. People often ask what is tirzepatide used for and whether it supports weight management goals.

Side Effects

After starting tirzepatide, many users notice gradual improvements in blood sugar levels over time. Some experience mild gastrointestinal effects early in treatment, which often lessen as the body adjusts. Consistent use as directed may help maintain steady glucose levels throughout the day.

Precautions & Warnings

Keep ZEPBOUND 15mg/0.5ml refrigerated between 2–8°C and avoid freezing. Protect from direct light and discard if the solution appears discolored or contains particles. Always use a new needle for each injection and follow proper disposal guidelines.

Avoid Interactions

Tirzepatide may interact with oral medications that rely on gastric emptying for absorption, such as certain antibiotics or contraceptives. Alcohol and other diabetes medications can affect blood sugar levels; consult a healthcare provider before combining therapies. CYP enzyme inhibitors may alter tirzepatide levels in the body.

Frequently Asked Questions

Tirzepatide is used to improve blood sugar control in adults with type 2 diabetes when combined with diet and exercise.

Store between 2–8°C and protect from light; do not freeze or expose to extreme temperatures.

Tirzepatide is primarily prescribed for blood sugar control, though some users may experience weight-related effects.

No, tirzepatide and semaglutide are different medications with distinct mechanisms of action.

Follow your healthcare provider’s guidance; do not take a double dose to make up for a missed injection.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.